Shares of StemCells (STEM -10.4%) are getting whacked today, after Roth Capital cut its rating...

|By:, SA News Editor

Shares of StemCells (STEM -10.4%) are getting whacked today, after Roth Capital cut its rating to Neutral from Buy due to a lack of catalysts over the near-term. The firm also slashed its price target to $1.80 from $5, in what only can be considered a markedly delayed response to the company's disappointing Q2 earlier in the month.